Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives

NCT04357535 · clinicaltrials.gov ↗

COMPLETED

Status

314

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)

Sponsor

Hakeam Abdulaziz Hakeam

Collaborators

[object Object]
[object Object]
[object Object]